|
Volumn 33, Issue 6, 2001, Pages 1527-1532
|
Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy
a b c d e f d b g g h e a b b c e f f |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
HEPATITIS B(E) ANTIGEN;
LAMIVUDINE;
PLACEBO;
VIRUS DNA;
ADOLESCENT;
ADULT;
ARTICLE;
CHINESE;
CHRONIC HEPATITIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DNA DETERMINATION;
DRUG TOLERABILITY;
FEMALE;
GENETIC VARIABILITY;
HEPATITIS B;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
SEROCONVERSION;
TREATMENT OUTCOME;
VIRUS DETECTION;
|
EID: 0034993211
PISSN: 02709139
EISSN: None
Source Type: Journal
DOI: 10.1053/jhep.2001.25084 Document Type: Article |
Times cited : (621)
|
References (19)
|